Jennison Associates LLC Has $54.98 Million Stock Position in LifeStance Health Group, Inc. (NASDAQ:LFST)

Jennison Associates LLC grew its position in LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 2.1% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 8,255,236 shares of the company's stock after acquiring an additional 168,856 shares during the quarter. Jennison Associates LLC owned about 2.12% of LifeStance Health Group worth $54,980,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of LFST. DekaBank Deutsche Girozentrale acquired a new stake in shares of LifeStance Health Group during the 1st quarter valued at $31,000. Xponance Inc. acquired a new position in shares of LifeStance Health Group in the 1st quarter valued at $69,000. Ameriprise Financial Inc. acquired a new position in LifeStance Health Group in the 4th quarter worth $87,000. Cibc World Markets Corp bought a new stake in shares of LifeStance Health Group in the 4th quarter valued at about $96,000. Finally, Forum Financial Management LP bought a new position in LifeStance Health Group in the 4th quarter valued at about $110,000. 85.50% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on the stock. Canaccord Genuity Group initiated coverage on shares of LifeStance Health Group in a research report on Thursday, April 3rd. They issued a "buy" rating and a $8.00 price target on the stock. KeyCorp assumed coverage on shares of LifeStance Health Group in a report on Tuesday, April 8th. They issued an "overweight" rating and a $9.00 target price for the company. Finally, UBS Group raised shares of LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $8.50 target price for the company in a research note on Tuesday, May 27th. One research analyst has rated the stock with a sell rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $8.50.

LifeStance Health Group Stock Down 4.5%

LFST stock traded down $0.20 during trading on Friday, hitting $4.22. 2,154,414 shares of the company's stock were exchanged, compared to its average volume of 1,680,687. The stock has a market capitalization of $1.64 billion, a price-to-earnings ratio of -42.20 and a beta of 1.16. LifeStance Health Group, Inc. has a 52-week low of $4.22 and a 52-week high of $8.61. The business has a 50-day moving average price of $5.29 and a two-hundred day moving average price of $6.57. The company has a current ratio of 1.47, a quick ratio of 1.47 and a debt-to-equity ratio of 0.19.

Insider Buying and Selling at LifeStance Health Group

In other LifeStance Health Group news, insider Ujjwal Ramtekkar sold 16,000 shares of LifeStance Health Group stock in a transaction that occurred on Thursday, June 5th. The stock was sold at an average price of $5.94, for a total transaction of $95,040.00. Following the sale, the insider directly owned 113,435 shares in the company, valued at $673,803.90. The trade was a 12.36% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 3.20% of the stock is owned by corporate insiders.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.